Home › Trial NCT01495247
Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
- Trial IDNCT01495247
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment18
- Start date2012-01-30
- ConditionsInoperable Locally Advanced Breast Cancer · Metastatic Breast Cancer (MBC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.